FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

2.

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

3.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

4.

Pancreatic cancer RNA vaccine shows durable T cell immunity

5.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot